In this video recap of the 2024 AANEM Annual Conference, Dr. Dianna Quan, MD, AANEM President and faculty at the University of Colorado School of Medicine, along with Dr. Donald Sanders, MD, neuromuscular neurologist, and Dr. Massey, MD, neuromuscular specialist from Duke University School of Medicine, discuss pivotal research findings. Key highlights include promising advances in plasma exosomes as biomarkers for diabetic peripheral neuropathy and the application of artificial intelligence in ultrasound imaging to differentiate between neurogenic and myogenic changes. They also review a study comparing the effectiveness of azathioprine and mycophenolate mofetil for myasthenia gravis, emphasizing the role of immunosuppressive therapies in treatment planning. Overall, the conference underscored the importance of integrating innovative research and technology to enhance diagnostic and treatment approaches in neuromuscular medicine.

The Immunoglobulin National Society (IgNS) 13th National Conference took place at the Gaylord National Resort & Convention Center in Washington, D.C., from Oct. 17 through 20, 2024. More than 1,200 nurses, pharmacists, physicians, and business leaders attended the four-day meeting.

The meeting featured the latest news and views on the treatment of myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, common variable immunodeficiency, primary immune thrombocytopenia, dermatomyositis, polymyositis, juvenile dermatomyositis, and other conditions.

Above, please find our postconference wrap-up report.

The 2024 annual meeting of the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) took place at the Savannah Convention Center and Westin Savannah Harbor in Georgia. Speakers at the four-day meeting covered the latest advances in neuromuscular and musculoskeletal disorders and electrodiagnostic medicine. The meeting also included sessions by the Myasthenia Gravis Foundation of America, Peripheral Nerve Society, and Dysautonomia International.

Above, please find our postconference wrap-up report, which takes a closer look at the myasthenia gravis data presented during the meeting.